Phathom Pharmaceuticals, Inc.
PHAT · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary
4 Item 1A. Risk Factors 26 Item 1B. Unresolved Staff Comments 77 Item 1C. Cybersecurity 77 Item 2. Properties 78 Item 3. Legal Proceedings 78 Item 4. Mine Safety Disclosures 78 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 79 Item 6. [Reserved] 79 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 80 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 92 Item 8....
Next Earnings
Q2 FY2026 — expected 2026-08-12
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | PHAT | discussed_in_filing Cybersecurity | |
| topic_mention | PHAT | discussed_in_filing Cybersecurity | |
| topic_mention | PHAT | discussed_in_filing Cybersecurity | |
| topic_mention | PHAT | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073379 | EDGAR | 94K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034183 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0000950170-24-027910 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-004875 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002536 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001564590-21-016682 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001564590-20-011712 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-10-30 | 2025-09-30 | 0001193125-25-257390 | EDGAR | 26K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104548 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000950170-25-061440 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123264 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093885 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056888 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061554 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-040977 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020109 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023160 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0000950170-22-013743 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0000950170-22-008741 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-02-26 | 0001193125-26-073377 | EDGAR | 4K words |
| 2026-01-08 | 0001193125-26-007660 | EDGAR | — |
| 2026-01-07 | 0001193125-26-006266 | EDGAR | — |
| 2025-11-04 | 0001193125-25-263534 | EDGAR | — |
| 2025-10-30 | 0001193125-25-257382 | EDGAR | — |
| 2025-10-27 | 0001193125-25-250611 | EDGAR | — |
| 2025-10-06 | 0001193125-25-230984 | EDGAR | — |
| 2025-08-07 | 0001193125-25-174943 | EDGAR | — |
| 2025-06-16 | 0001193125-25-141119 | EDGAR | — |
| 2025-06-09 | 0001193125-25-137800 | EDGAR | — |
141 total filings indexed. 112 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001783183 |
| Ticker | PHAT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 362ce072d5db483b5aca5abfcd273f4036031e6da1b7c080ed1bf918cfc1f422
parent: d6a4ef45996f6cce987117775b953017c5f762d23bb95f15ee78cacae1764df7
content hash: 9fbaa00c4cb8f1f2db177e3694058347be95270879184c50fbcec6600f50f447
signed: 2026-04-13T04:46:53.519Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf